Mingen Lin

672 total citations · 1 hit paper
18 papers, 473 citations indexed

About

Mingen Lin is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Mingen Lin has authored 18 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Mingen Lin's work include Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (3 papers). Mingen Lin is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune Cell Function and Interaction (3 papers). Mingen Lin collaborates with scholars based in China, United States and India. Mingen Lin's co-authors include Lei Lv, Yan Lin, Ming‐Liang Lai, Jin‐ding Huang, Chuanmin Cheng, Yanping Xu, Ruonan Zhang, Wenjing Dong, Tongguan Tian and Jing He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Cancer Research.

In The Last Decade

Mingen Lin

17 papers receiving 470 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1

2022 160 citations Ruonan Zhang, Yajing Yang et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mingen Lin China	8	202	178	135	80	58	18	473
Wataru Obuchi Japan	8	209 1.0×	211 1.2×	78 0.6×	25 0.3×	48 0.8×	15	487
Agnès Basseville United States	11	321 1.6×	239 1.3×	35 0.3×	39 0.5×	56 1.0×	18	521
Maria Teresa Landi United States	9	293 1.5×	241 1.4×	59 0.4×	59 0.7×	100 1.7×	18	604
Naoaki Murao Japan	15	205 1.0×	161 0.9×	56 0.4×	43 0.5×	15 0.3×	26	624
Norihisa Ohishi Japan	11	115 0.6×	94 0.5×	64 0.5×	79 1.0×	30 0.5×	19	354
Pia Wegman Sweden	10	207 1.0×	281 1.6×	313 2.3×	43 0.5×	102 1.8×	14	635
Katsuyoshi Kawana Japan	8	139 0.7×	125 0.7×	103 0.8×	61 0.8×	26 0.4×	11	519
Chong-Sheng Chen United States	9	187 0.9×	113 0.6×	98 0.7×	14 0.2×	61 1.1×	10	362
Cheng‐Pang Hsu United States	10	186 0.9×	148 0.8×	26 0.2×	49 0.6×	24 0.4×	22	379

Countries citing papers authored by Mingen Lin

Since Specialization

Citations

This map shows the geographic impact of Mingen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingen Lin more than expected).

Fields of papers citing papers by Mingen Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingen Lin. The network helps show where Mingen Lin may publish in the future.

Co-authorship network of co-authors of Mingen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Mingen Lin. A scholar is included among the top collaborators of Mingen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingen Lin. Mingen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Lin, Mingen, Fei Teng, Yan Ma, et al.. (2025). TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma. Cell Death and Disease. 16(1). 438–438.

Dai, Yue, Song Fan, Kai Wang, et al.. (2025). Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma. Cell Death and Disease. 16(1). 71–71. 4 indexed citations

Dong, Wenjing, Mingen Lin, Ruonan Zhang, et al.. (2024). d-mannose targets PD-1 to lysosomal degradation and enhances T cell-mediated anti-tumor immunity. Cancer Letters. 591. 216883–216883. 6 indexed citations

Lin, Mingen, et al.. (2024). GABA/baclofen stabilizes PD-L1 and enhances immunotherapy of breast cancer. Heliyon. 10(7). e28600–e28600. 7 indexed citations

He, Jing, Mingen Lin, Xinchao Zhang, et al.. (2023). TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential. Cell Discovery. 9(1). 84–84. 9 indexed citations

Tian, Tongguan, Wanwan Yi, Yixin Xu, et al.. (2023). FBXO38 mediates FGL1 ubiquitination and degradation to enhance cancer immunity and suppress inflammation. Cell Reports. 42(11). 113362–113362. 13 indexed citations

Lin, Mingen, Jing He, Wenjing Dong, et al.. (2023). Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma. Journal of Clinical Investigation. 133(9). 38 indexed citations

Lin, Mingen, Xue Sun, & Lei Lv. (2023). New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer. Molecular Therapy — Oncolytics. 29. 91–106. 7 indexed citations

Zhang, Ruonan, Yajing Yang, Wenjing Dong, et al.. (2022). D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1. Proceedings of the National Academy of Sciences. 119(8). 160 indexed citations breakdown →

10.

Li, Shuyan, Jing He, Ruonan Zhang, et al.. (2022). TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling. Cancer Research. 82(11). 2097–2109. 34 indexed citations

11.

Zhang, Zhiqin, et al.. (2022). Identification of the Putative Tumor Suppressor Characteristics of FAM107A via Pan-Cancer Analysis. Frontiers in Oncology. 12. 861281–861281. 4 indexed citations

12.

Lin, Mingen, et al.. (2020). Role of betaine in inhibiting the induction of RNA Pol III gene transcription and cell growth caused by alcohol. Chemico-Biological Interactions. 325. 109129–109129. 11 indexed citations

13.

Lin, Mingen, Chenghao Huang, Wenfeng Ren, et al.. (2020). Mitogen- and Stress-Activated Protein Kinase 1 Mediates Alcohol-Upregulated Transcription of Brf1 and tRNA Genes to Cause Phenotypic Alteration. Oxidative Medicine and Cellular Longevity. 2020. 1–13. 6 indexed citations

14.

Yao, Yousheng, et al.. (2015). Unexplained association between cystitis glandularis and interstitial cystitis in females: a retrospective study. International Urogynecology Journal. 26(12). 1835–1841. 3 indexed citations

15.

Lin, Mingen, et al.. (2005). Surface approximation based image simplification and applications. 3. 2988–2993. 1 indexed citations

16.

Lin, Yan, et al.. (2001). Novel mutations of CYP3A4 in Chinese.. PubMed. 29(3). 268–73. 161 indexed citations

17.

Lin, Mingen, et al.. (1993). Effects of 5-hydroxymethyl-2′-deoxyuridine and 3-aminobenzamide on chromosome aberrations in cultured human lymphocytes. Mutation Research Letters. 301(4). 229–233. 4 indexed citations

18.

Lin, Mingen, et al.. (1984). Ultraviolet light and mitomycin C induced sister-chromatid exchanges in fibroblasts from patients with retinoblastoma. Mutation Research Letters. 141(2). 101–104. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact